Synthesis and Structure-Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors

被引:70
|
作者
Wu, Bobin [1 ]
Yang, Yanchun [1 ]
Qin, Xiangyu [1 ]
Zhang, Shuzhen [1 ]
Jing, Chaojun [1 ]
Zhu, Changjin [1 ]
Ma, Bing [1 ]
机构
[1] Beijing Inst Technol, Dept Appl Chem, Beijing 100081, Peoples R China
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
aldehyde reductases; aldose reductases; diabetes complications; inhibitors; polyol pathway; quinoxalines; structure-activity relationships; ACETIC-ACID DERIVATIVES; DIABETIC COMPLICATIONS; ANTIOXIDANT ACTIVITY; ALDEHYDE REDUCTASE; POTENT INHIBITORS; HIGHLY POTENT; SELECTIVITY; 1,1-DIOXIDE; ANTAGONISTS; CONGENERS;
D O I
10.1002/cmdc.201300324
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors of aldose reductase (AR), a novel target for the treatment of diabetes complications. Most of the derivatives proved to be potent and selective, with IC50 values in the low nanomolar to micromolar range. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:1913 / 1917
页数:5
相关论文
共 50 条
  • [1] Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors
    Hussain, Saghir
    Parveen, Shagufta
    Hao, Xin
    Zhang, Shuzhen
    Wang, Wei
    Qin, Xiangyu
    Yang, Yanchun
    Chen, Xin
    Zhu, Shaojuan
    Zhu, Changjin
    Ma, Bing
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 80 : 383 - 392
  • [2] Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity
    Hao, Xin
    Han, Zhongfei
    Li, Yang
    Li, Chenying
    Wang, Xing
    Zhang, Xin
    Yang, Qin
    Ma, Bing
    Zhu, Changjin
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (04) : 887 - 892
  • [3] Quantitative structure-activity relationship studies of a new class of selective aldose reductase inhibitors
    Sharma, R.
    Sahoo, P. K.
    Chaturvedi, S. C.
    [J]. INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2008, 47 (06): : 957 - 962
  • [4] Design, Synthesis and Structure-Activity Relationship Study of Aldose Reductase Inhibitors Based on Quinoxalinone Structure
    Ma B.
    Fan Z.
    Wang X.
    Li C.
    Zhu C.
    [J]. Beijing Ligong Daxue Xuebao/Transaction of Beijing Institute of Technology, 2021, 41 (04): : 445 - 450
  • [5] Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship
    Juskova, Maria
    Majekova, Magdalena
    Demopoulos, Vassilis
    Stefek, Milan
    [J]. GENERAL PHYSIOLOGY AND BIOPHYSICS, 2011, 30 (04) : 342 - 349
  • [6] Synthesis and structure-activity relationship study of aldose reductase inhibiting marine alkaloid lukianol A and its derivatives
    Ishibashi, Fumito
    Zha, Shijiao
    Kondo, Taiyo
    Sakamoto, Mayu
    Ueno, Mikinori
    Fukuda, Tsutomu
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2023, 87 (02) : 148 - 157
  • [7] SYNTHESIS AND THE FIRST STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF IMIDAZOLE ALKALOID FROM RED ASCIDIAN AS ALDOSE REDUCTASE INHIBITORS
    Morikawa, Kenta
    Uno, Sota
    Higashi, Shoko
    Goto, Masaru
    Saito, Ryota
    [J]. HETEROCYCLES, 2019, 98 (08) : 1130 - 1141
  • [8] STRUCTURE-ACTIVITY RELATIONSHIP OF ALDOSE REDUCTASE INHIBITORS BASED ON X-RAY CRYSTAL-STRUCTURES OF OXAZOLECARBAMATE DERIVATIVES
    ISHIDA, T
    IN, Y
    OHISHI, H
    YAMAMOTO, D
    INOUE, M
    TANAKA, C
    UENO, Y
    OHMOMO, Y
    KANDA, N
    TANAKA, A
    TANIMOTO, T
    [J]. MOLECULAR PHARMACOLOGY, 1988, 34 (03) : 377 - 387
  • [9] STRUCTURE-ACTIVITY STUDIES ON ALDOSE REDUCTASE AND ALDEHYDE REDUCTASE-II
    BHATNAGAR, A
    DAS, B
    SRIVASTAVA, SK
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (06) : 1971 - 1971
  • [10] Strategies in synthetic design and structure-activity relationship studies of novel heterocyclic scaffolds as aldose reductase-2 inhibitors
    Yahya, Shaikh
    Haider, Kashif
    Pathak, Ankita
    Choudhary, Akram
    Hooda, Pooja
    Shafeeq, Mohd
    Shahar Yar, Mohammad
    [J]. ARCHIV DER PHARMAZIE, 2022, 355 (12)